Literature DB >> 18974740

Pathways to cancer therapy.

Dan Jones.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18974740     DOI： 10.1038/nrd2748

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  15 in total

1.  News feature: 2008 in reflection.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

2.  Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.

Authors:  Xinyan Zhang; Yan Li; Tomi Akinyemiju; Akinyemi I Ojesina; Phillip Buckhaults; Nianjun Liu; Bo Xu; Nengjun Yi
Journal:  Genetics       Date:  2016-11-09       Impact factor: 4.562

3.  Prediction of Novel Drugs and Diseases for Hepatocellular Carcinoma Based on Multi-Source Simulated Annealing Based Random Walk.

Authors:  S Jafar Ali Ibrahim; M Thangamani
Journal:  J Med Syst       Date:  2018-09-01       Impact factor: 4.460

Review 4.  Translational disease interpretation with molecular networks.

Authors:  Anaïs Baudot; Gonzalo Gómez-López; Alfonso Valencia
Journal:  Genome Biol       Date:  2009-06-29       Impact factor: 13.583

5.  A Boolean approach to linear prediction for signaling network modeling.

Authors:  Federica Eduati; Alberto Corradin; Barbara Di Camillo; Gianna Toffolo
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

6.  Prediction of deleterious non-synonymous SNPs based on protein interaction network and hybrid properties.

Authors:  Tao Huang; Ping Wang; Zhi-Qiang Ye; Heng Xu; Zhisong He; Kai-Yan Feng; Lele Hu; Weiren Cui; Kai Wang; Xiao Dong; Lu Xie; Xiangyin Kong; Yu-Dong Cai; Yixue Li
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

7.  Pathway index models for construction of patient-specific risk profiles.

Authors:  Kevin H Eng; Sijian Wang; William H Bradley; Janet S Rader; Christina Kendziorski
Journal:  Stat Med       Date:  2012-10-16       Impact factor: 2.373

Review 8.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.

Authors:  Timothy R Hercus; Daniel Thomas; Mark A Guthridge; Paul G Ekert; Jack King-Scott; Michael W Parker; Angel F Lopez
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

9.  Discriminating between deleterious and neutral non-frameshifting indels based on protein interaction networks and hybrid properties.

Authors:  Ning Zhang; Tao Huang; Yu-Dong Cai
Journal:  Mol Genet Genomics       Date:  2014-09-24       Impact factor: 3.291

10.  Identification of disease treatment mechanisms through the multiscale interactome.

Authors:  Camilo Ruiz; Marinka Zitnik; Jure Leskovec
Journal:  Nat Commun       Date:  2021-03-19       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.